Two Sigma Investments, LP Bio Affinity Technologies, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.99 - $1.9 $198 - $380
-200 Reduced 0.92%
21,642 $25,000
Q2 2023

Aug 14, 2023
SELL
$1.56 - $2.05 $7,402 - $9,727
-4,745 Reduced 17.85%
21,842 $39,000
Q1 2023

May 15, 2023
BUY
$1.52 - $3.06 $40,412 - $81,356
26,587 New
26,587 $50,000

Others Institutions Holding BIAF

# of Institutions
15
Shares Held
468K
Call Options Held
0
Put Options Held
0
View Full List

About bioAffinity Technologies, Inc.

BIAF Quotes by TradingView
  • Ticker BIAF
  • Exchange
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 2,727,580
  • Market Cap $2.43M
  • Description
  • bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...
More about BIAF
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email